2025/10/17 by Sandra Lauck, Francesco Saia, Éric Durand +44 · 2 voices
Medicine · #Cardiac Valve Diseases and Treatments #Clinical practice guidelines implementation #Aortic Disease and Treatment Approaches
paper · doi:10.1016/j.shj.2025.100740
openalex publication_date 2025/10/17 · openalex created_date 2025/10/17 · openalex updated_date 2026/07/22
Background: Transcatheter aortic valve implantation (TAVI) treatment pathways can be supported by a dedicated clinical valve coordinator (CVC), enhancing their efficiency. We aimed to evaluate the impact of a CVC in managing the treatment pathway of patients undergoing TAVI across Europe before and after implementing 8 Benchmark best practices. Methods: The BENCHMARK registry (ClinicalTrials NCT04579445) was a multicenter international study of patients with severe symptomatic aortic stenosis undergoing TAVI with balloon-expandable valves across 28 European centers. Primary outcomes were hospital and intensive care length of stay (LoS). The secondary outcome was 30-day patient safety. Results: < 0.001). Conclusions: The addition of a CVC to the multidisciplinary team and their sustained contributions to processes of care align with the implementation of Benchmark practices, significantly decrease the health service requirements of TAVI patients, and are associated with improved patient-reported experiences.